Cargando…

Interleukin-6-to-Albumin Ratio as a Superior Predictor of Mortality in End-Stage Kidney Disease Patients

INTRODUCTION: In patients with chronic kidney disease (CKD), high interleukin-6 (IL-6) and low albumin circulating concentrations are associated with worse outcomes. We examined the IL-6-to-albumin ratio (IAR) as a predictor of risk of death in incident dialysis patients. METHODS: In 428 incident di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiejia, Qureshi, Abdul Rashid, Suliman, Mohamed E., Heimbürger, Olof, Barany, Peter, Stenvinkel, Peter, Lindholm, Bengt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Patient-Oriented, Translational Research: Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623391/ https://www.ncbi.nlm.nih.gov/pubmed/37231796 http://dx.doi.org/10.1159/000531191

Ejemplares similares

The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease
por: Alves, Filipa Caeiro, et al.
Publicado: (2018)

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients
por: Dai, Lu, et al.
Publicado: (2017)

Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients
por: Sjöberg, Bodil, et al.
Publicado: (2014)

Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients
por: Chen, Zhimin, et al.
Publicado: (2019)

Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease
por: Mukai, Hideyuki, et al.
Publicado: (2018)

Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
por: Missailidis, Catharina, et al.
Publicado: (2016)

Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study
por: Pei, Ming, et al.
Publicado: (2019)

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
por: Jankowska, Magdalena, et al.
Publicado: (2017)

Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients
por: Danielson, Kristin, et al.
Publicado: (2014)

Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease
por: Machowska, Anna, et al.
Publicado: (2016)

Central obesity as assessed by conicity index and a-body shape index associates with cardiovascular risk factors and mortality in kidney failure patients
por: Ryu, Kakei, et al.
Publicado: (2023)

Copeptin is independently associated with vascular calcification in chronic kidney disease stage 5
por: Golembiewska, Edyta, et al.
Publicado: (2020)

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients
por: Molanaei, Hadi, et al.
Publicado: (2018)

Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients
por: Dekker, Shosha E.I., et al.
Publicado: (2022)

Selection of Genetic and Phenotypic Features Associated with Inflammatory Status of Patients on Dialysis Using Relaxed Linear Separability Method
por: Bobrowski, Leon, et al.
Publicado: (2014)

Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans
por: Bonde, Ylva, et al.
Publicado: (2014)

A cohort study of insulin-like growth factor 1 and mortality in haemodialysis patients
por: Nilsson, Erik, et al.
Publicado: (2016)

Comparative quantitative systems pharmacology modeling of anti-PCSK9 therapeutic modalities in hypercholesterolemia
por: Sokolov, Victor, et al.
Publicado: (2019)

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease
por: Feldreich, Tobias, et al.
Publicado: (2018)

Bone mineral density and mortality in end-stage renal disease patients
por: Iseri, Ken, et al.
Publicado: (2020)

High-sensitivity troponins in dialysis patients: variation and prognostic value
por: Snaedal, Sunna, et al.
Publicado: (2020)

Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy
por: Witasp, Anna, et al.
Publicado: (2022)

Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma
por: Velagapudi, Srividya, et al.
Publicado: (2018)

Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis
por: Koska, Juraj, et al.
Publicado: (2022)

Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study
por: Dai, Lu, et al.
Publicado: (2021)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
por: Abdel-Khalik, Jonas, et al.
Publicado: (2017)

Lipid levels are inversely associated with infectious and all-cause mortality: international MONDO study results(1)
por: Kaysen, George A., et al.
Publicado: (2018)

Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia
por: Meikle, Peter J., et al.
Publicado: (2015)

Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis
por: Höflinger, Philip, et al.
Publicado: (2021)

Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease
por: Dai, Lu, et al.
Publicado: (2019)

MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines(1)
por: Burla, Bo, et al.
Publicado: (2018)

Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
por: Deshmukh, Harshal A., et al.
Publicado: (2012)

Chronic inflammation in end-stage renal disease and dialysis
por: Cobo, Gabriela, et al.
Publicado: (2018)

Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease
por: Meuwese, Christiaan Lucas, et al.
Publicado: (2015)

Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism
por: Bishop, Charles W., et al.
Publicado: (2022)

Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial
por: Cherney, David Z.I., et al.
Publicado: (2022)

Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)
por: Gang, Sishir, et al.
Publicado: (2022)

Trends in Adherence to Recommended Physical Activity and Its Association with Mortality and Disease Progression among US Adults with Chronic Kidney Disease
por: Qu, Xiaolin, et al.
Publicado: (2022)

Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials
por: Agarwal, Rajiv, et al.
Publicado: (2023)

Comparison between the Effects of Allopurinol and Febuxostat on the Survival of Patients on Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_phtv6e6a5hb5124h7or9lk2q32